Selvita, the largest drug discovery company in Central and Eastern Europe, has just opened its West Coast U.S. office, located in San Bruno, CA.
Selvita has initiated its U.S. operations in September 2015, opening a fully-owned U.S. subsidiary, Selvita Inc., headquartered in Cambridge, MA. Now, the company is officially opening its second office, which is dedicated to the support of the ongoing and future projects for business partners from the West Coast of U.S. The office is located at 1001 Bayhill Drive, in San Bruno, California.
“The U.S. drug discovery market is absolutely strategic for Selvita. It is not only where most of our revenue comes from, but also where we put most of our hopes in,” said Pawel Przewiezlikowski, Chief Executive Officer at Selvita.
“We are continuously investing in top class-facilities and best professionals,” said Przewiezlikowski. “In 2016 we are opening our second research facility in Poznan, Poland, and we believe we have even more to offer to our customers.
“The last several months of our operations on the U.S. East Coast, have shown that our local presence is not only bringing us closer to our U.S clients, but also facilitating a swifter bidirectional transfer of know-how between our labs in Poland and the partner base in the U.S.
“Having two U.S offices located in where the heart of the biotechnology industry beats—in Greater Boston and in the San Francisco Bay areas—is what will definitely bring us closer to achieving our goal of becoming the drug discovery partner of choice for the U.S. biotech and pharma industry.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
